Status:
COMPLETED
Analgesic Effectiveness of Three Different Doses of a New Formulation of Lamaline in a Model of Painful Knee (Gonarthrosis)
Lead Sponsor:
Solvay Pharmaceuticals
Conditions:
Knee Osteoarthritis
Eligibility:
All Genders
40-85 years
Phase:
PHASE3
Brief Summary
This study aims to assess the analgesic effectiveness and safety of three different doses of a new formulation of Lamaline® versus Dafalgan® Codeine after 10 days administration in subjects with painf...
Eligibility Criteria
Inclusion
- History of knee (unilateral or bilateral) osteoarthritis for at least 6 months
- Pain intensity assessed by Visual Analogue Scale ≥ 40 mm
- Partial functional disability assessed by Lequesne index ≥4 and \< than 12
Exclusion
- Patient unable to interrupt his/her NSAIDs to participate in the clinical study
Key Trial Info
Start Date :
December 1 2005
Trial Type :
INTERVENTIONAL
End Date :
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00264225
Start Date
December 1 2005
Last Update
February 20 2008
Active Locations (171)
Enter a location and click search to find clinical trials sorted by distance.
1
Site 2
Albi, France
2
Site 3
Andernos-les-Bains, France
3
Site 101
Angers, France
4
Site 103
Angers, France